Showing 901 - 920 results of 11,927 for search '"Hepatocellular carcinoma"', query time: 0.18s Refine Results
  1. 901
  2. 902

    Efficacy of Local Treatment in Lymph Node Metastasis from Hepatocellular Carcinoma by Byung min Lee, Jin-Young Choi, Jinsil Seong

    Published 2023-01-01
    “…Introduction: We aimed to investigate the significance of lymph node metastasis from hepatocellular carcinoma and the efficacy of local treatment. …”
    Get full text
    Article
  3. 903
  4. 904
  5. 905

    MIF is a critical regulator of mononuclear phagocytic infiltration in hepatocellular carcinoma by Yunxi Liao, Chenyang Wu, Yang Li, Jinhua Wen, Dongyu Zhao

    Published 2023-08-01
    “…To elucidate the underlying processes involved in mononuclear phagocyte (MNP) infiltration and phenotypic changes in hepatocellular carcinoma (HCC), we integrated single-cell RNA-sequencing data from 100,030 cells derived from patients with HCC and healthy individuals and compared the phenotypes and origins of the MNPs in the tumor core, tumor periphery, adjacent normal tissue, and healthy liver samples. …”
    Get full text
    Article
  6. 906
  7. 907

    Immunopeptidome of hepatocytes isolated from patients with HBV infection and hepatocellular carcinoma by Monique T.A. de Beijer, Karel Bezstarosti, Robbie Luijten, Wouter A.S. Doff, Patrick P.C. Boor, Roel F.A. Pieterman, Rachid Bouzid, Paula J. Biesta, Jan N.M. Ijzermans, Michail Doukas, Robert A. de Man, Andrea M. Woltman, Jeroen A.A. Demmers, Sonja I. Buschow

    Published 2022-11-01
    “…Background & Aims: Antigen-specific immunotherapy is a promising strategy to treat HBV infection and hepatocellular carcinoma (HCC). To facilitate killing of malignant and/or infected hepatocytes, it is vital to know which T cell targets are presented by human leucocyte antigen (HLA)-I complexes on patient-derived hepatocytes. …”
    Get full text
    Article
  8. 908

    Curcumin- and resveratrol-co-loaded nanoparticles in synergistic treatment of hepatocellular carcinoma by Yongshun Zheng, Ran Jia, Jun Li, Xiaohe Tian, Yeben Qian

    Published 2022-07-01
    “…Abstract Background Currently, systemic therapies for patients with advanced-stage hepatocellular carcinoma (HCC) rely mainly on systemic drugs. …”
    Get full text
    Article
  9. 909
  10. 910
  11. 911
  12. 912

    Identification of Anoikis-Related Subgroups and Prognosis Model in Liver Hepatocellular Carcinoma by Yutong Chen, Weiran Huang, Jian Ouyang, Jingxiang Wang, Zhengwei Xie

    Published 2023-02-01
    “…However, the mechanism of anoikis in hepatocellular carcinoma (HCC) remains unknown. In this study, we applied differentially expressed overlapping anoikis-related genes to classify The Cancer Genome Atlas (TCGA) samples using an unsupervised cluster algorithm. …”
    Get full text
    Article
  13. 913
  14. 914
  15. 915

    Management of early-stage hepatocellular carcinoma: challenges and strategies for optimal outcomes by Jae Hyun Yoon, Sung Kyu Choi

    Published 2023-09-01
    “…Although hepatocellular carcinoma (HCC) is associated with a poor prognosis, management of early-stage HCC is often successful with highly efficacious treatment modalities such as liver transplantation, surgical resection, and radiofrequency ablation. …”
    Get full text
    Article
  16. 916
  17. 917
  18. 918
  19. 919

    Landscape of immunocytes infiltration and prognostic immune-related genes in hepatocellular carcinoma by Yanze Yin, Yi Luo, Kang He

    Published 2023-10-01
    “…Background: /Objective: The therapeutic efficacy and prognosis of patients with hepatocellular carcinoma (HCC) remain unsatisfactory, and further studies are supposed to provide more effective treatment strategies. …”
    Get full text
    Article
  20. 920